Gallbladder cancer: Epidemiology and outcome

Clinical Epidemiology

Volumn 6, Issue 1, 2014, Pages 99-109

  Hundal, Rajveer ^a   Shaffer, Eldon A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anomalous junction of the pancreaticobiliary duct; Cholecystectomy; Cholelithiasis; Gallbladder polyp; Gallstones; Incidence; Primary sclerosing cholangitis

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROPYRIMIDINE; FLUOROURACIL; GEMCITABINE; PLATINUM DERIVATIVE;

AMERICAN INDIAN; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; CHOLECYSTECTOMY; CHOLELITHIASIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; GALLBLADDER CANCER; GENETIC PREDISPOSITION; HUMAN; INCIDENCE; MORTALITY; OBESITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREVALENCE; PRIMARY PREVENTION; PRIMARY SCLEROSING CHOLANGITIS; PROGRESSION FREE SURVIVAL; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SEX DIFFERENCE; SOUTHEAST ASIA; SURVIVAL RATE; TOBACCO CONSUMPTION; ULTRASOUND;

EID: 84897886323     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S37357     Document Type: Review

References (74)

1. Lazcano-Ponce EC, Miquel JF, Muñoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA: Cancer J Clin. 2001. 2001;51(6):349-364.
2. Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol. 2000;95(6):1402-1410.
3. Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98(7):485-489.
4. Levy AD, Murakata LA, Rohrmann CA Jr. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics. 2001;21(2):295-314; questionnaire, 549-555.
5. Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4(9):695-706.
6. Surveillance, Epidemiology and End-Results Program (SEER). The Four Most Common Cancers for Different Ethnic Populations 2013. Bethesda, MD: National Cancer Institute; 2013.
7. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118(7): 1591-1602.
8. Konstantinidis IT, Deshpande V, Genevay M, et al. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg. 2009;144(5):441-447.
9. Gupta P, Agarwal A, Gupta V, Singh PK, Pantola C, Amit S. Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer. Gastrointest Cancer Res. 2012;5(2): 41-47.
10. Curado MP, Edwards B, Shin HR, et al, editors. Cancer Incidence in Five Continents, Vol IX. Lyon: International Agency for Research on Cancer; 2007.
11. Surveillance, Epidemiology and End-Results Program (SEER). The Four Most Common Cancers for Different Ethnic Populations 2013. Bethesda, MD: National Cancer Institute; 2013.
12. Zatonski WA, Lowenfels AB, Boyle P, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst. 1997;89(15):1132-1138.
13. Sampliner RE, Bennett PH, Comess LJ, Rose FA, Burch TA. Gallbladder disease in Pima Indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med. 1970;283(25):1358-1364.
14. Everhart JE, Yeh F, Lee ET, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology. 2002;35(6):1507-1512.
15. Miquel JF, Covarrubias C, Villaroel L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology. 1998;115(4):937-946.
16. Singh V, Trikha B, Nain C, Singh K, Bose S. Epidemiology of gallstone disease in Chandigarh: a community-based study. J Gastroenterol Hepatol. 2001;16(5):560-563.
17. Koea J, Phillips A, Lawes C, Rodgers M, Windsor J, McCall J. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival. ANZ J Surg. 2002;72(12):857-861.
18. Stringer MD, Fraser S, Gordon KC, Sharples K, Windsor JA. Gallstones in New Zealand: composition, risk factors and ethnic differences. ANZ J Surg. 2013;83(7-8):575-580.
19. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6(2):172-187.
20. Lowenfels AB, Walker AM, Althaus DP, Townsend G, Domellöf L. Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol. 1989;18(1):50-54.
21. Diehl AK. Gallstone size and the risk of gallbladder cancer. JAMA. 1983;250(17):2323-2326.
22. Shaffer EA. Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006;20(6):981-996.
23. Shaffer EA. Gallbladder cancer: the basics. Gastroenterol Hepatol (N Y). 2008;4(10):737-741.
24. Le MD, Henson D, Young H, Albores-Saavedra J. Is gallbladder cancer decreasing in view of increasing laparoscopic cholecystectomy? Ann Hepatol. 2011;10(3):306-314.
25. Rashid A, Ueki T, Gao YT, et al. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. Clin Cancer Res. 2002;8(10):3156-3163.
26. Berk RN, Armbuster TG, Saltzstein SL. Carcinoma in the porcelain gallbladder. Radiology. 1973;106(1):29-31.
27. Stephen AE, Berger DL. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery. 2001;129(6):699-703.
28. Cunningham SC, Alexander HR. Porcelain gallbladder and cancer: ethnicity explains a discrepant literature? Am J Med. 2007;120(4): e17-e18.
29. Schnelldorfer T. Porcelain gallbladder: a benign process or concern for malignancy? J Gastrointest Surg. 2013;17(6):1161-1168.
30. Kumar S. Infection as a risk factor for gallbladder cancer. J. Surg. Oncol. 2006;93(8):633-639.
31. Gonzalez-Escobedo G, Marshall JM. Chronic and acute infection of the gall bladder by Salmonella Typhi: understanding the carrier state. Nature Reviews: Microbiology. January 2011;9(1):9-14.
32. Saetta AA. K-ras, p53 Mutations, and Microsatellite Instability (MSI) in Gallbladder Cancer. J. Surg. Oncol. June 15, 2006;93(8):644-649.
33. Razumilava N, Gores GJ, Lindor KD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology. October 28, 2011;54(5):1842-1852.
34. Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC. Prevalence and Risk Factors for Gallbladder Neoplasia in Patients With Primary Sclerosing Cholangitis: Evidence for a Metaplasia-Dysplasia-Carcinoma Sequence. American Journal of Surgical Pathology. June 1, 2007;31(6):907-913.
35. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. February 2010;51(2):660-678.
36. European Association for the Stud. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. Journal of Hepatology. August 2009;51(2):237-267.
37. Pandey M. Environmental pollutants in gallbladder carcinogenesis. J. Surg. Oncol. 2006;93(8):640-643.
38. Lubin JH, Boice JD, Edling C, Hornung RW, Howe GR, Kunz E, et al. Lung Cancer in Radon-Exposed Miners and Estimation of Risk From Indoor Exposure. Journal of the National Cancer Institute. June 7, 1995;87(11):817-827.
39. Darby SC, Whitley E, Howe GR, Hutchings SJ, Kusiak RA, Lubin JH, et al., editors. Radon and Cancers Other Than Lung Cancer in Underground Miners: a Collaborative Analysis of 11 Studies. Journal of the Cancer Institute. March 1, 1995;87(5):378-384.
40. Jain K, Sreenivas V, Velpandian T, Kapil U, Garg PK. Risk factors for gallbladder cancer: A case-control study. Int. J. Cancer. September 21, 2012;132(7):1660-1666.
41. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, Obesity, and Mortlity from Cancer in a Prospectively Studied Cohort of U.S. Adults. The New England Journal of Medicine. April 24, 2003;348(17):1625-1638.
42. Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for gallbladder cancer across the world. MHPB. 2008;10(5):327-331.
43. Wolin KY, Carson K, Colditz GA. Obesity and Cancer. The Oncologist. June 24, 2010;15(6):556-565.
44. Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. British Journal of Cancer. May 7, 2007;96(9):1457-1461.
45. Lai HC, Chang SN, Lin CC, Chen CC, Chou JW, Peng CY, et al. Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study. J Gastroenterol. July 2013;48(7):856-865.
46. Myers RP, Shaffer EA. Gallbladder polyps: Epidemiology, natural history and management. Canadian Journal of Gastroenterology. March 2002;16(3):187-194.
47. Gallahan WC, Conway JD. Diagnosis and Management of Gallbladder Polyps. Gastroenterology & Hepatology. June 2010;39(2):359-367.
48. Jorgensen T, Jensen KH. Polyps in the gallbladder. A prevalence study. Scandinavian Journal of Gastroenterology; March 1990;25(3):281-286.
49. Roa I, de Aretxabala X, Morgan R, Molina R, Araya JC, Roa J, et al. Clinicopathological features of gallbladder polyps and adenomas. Revista Medica de Chile; June 2004;132(6):673-679.
50. Terzi C, Sokmen S, Seckin S, Albayrak L, Ugurlu M. Polypoid Lesions of the Gallbladder: Report of 100 cases with special reference to operative indications. Surgery. June 2000;127(6):622-627.
51. Nuzzo G, Clemente G, Cadeddu F, Ardito F, Ricci R, Vecchio FM. Papillary carcinoma of the gallbladder and anomalous pancreatico-biliary junction. Report of three cases and review of the literature. Hepatogastroenterology; July-August 2005;52(64):1034-1038.
52. Nomura T, Shirai Y, Sandoh N, Nagakura S, Hatakeyama K. Cholangiographic criteria for anomalous union of the pancreatic and biliary ducts. Gastrointestinal Endoscopy. February 2002;55(2):204-208.
53. Dutta U, Nagi B, Garg PK, Sinha SK, Singh K, Tandon RK. Patients with gallstones develop gallbladder cancer at an earlier age. European Journal of Cancer Prevention. August 2005;14(4):381-385.
54. Dutta U. Gallbladder cancer: Can newer insights improve the outcome? Journal of Gastroenterology and Hepatology. March 22, 2012;27(4):642-653.
55. Itol T, Watanabe H, Ajioka Y, Oohashl Y, Takei K, Nishikura K, et al. APC, K-ras codon 12 mutations and p 5 3 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis. Pathology International. May 1996;46(5):333-340.
56. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer Staging Manual 2010 Springer.
57. Ouchi K, Mikuni J. Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. Journal of Hepatobiliary and Pancreatic Surgery. 2002;9(2):256-260.
58. Boutros C, Gary M, Baldwin K, Somasundar P. Gallbladder cancer: Past, present and an uncertain future. Surg Oncol. 2012;21(4):e183-e191.
59. Gallbladder Cancer: Comparison of Patients Presenting Initially for Definitive Operation With Those Presenting After Prior Noncurative Intervention. Ann Surg. 2000;232(4):557-569.
60. Goldin RD, Roa JC. Gallbladder cancer: a morphological and molecular update. Histopathology. 2009;55(2):218-229.
61. Jayaraman S, Jarnagin WR. Management of Gallbladder Cancer. Gastroenterol Clin North Am. 2010;39(2):331-342.
62. Joo I, Lee JY, Kim JH, Kim SJ, Kim MA, Han JK, Choi BI. Differentiation of adenomyomatosis of the gallbladder from early-stage, wall-thickening-type gallbladder cancer using high-resolution ultrasound. Eur Radiol. 2012;23(3):730-8.
63. Kim HJ, Lee SK, Jang JW, et al. Diagnostic role of endoscopic ultrasonography-guided fine needle aspiration of gallbladder lesions. Hepatogastroenterology. 2012;59(118):1691-1695.
64. Kumaran V, Gulati MS, Paul SB, Kumar Pande G, Sahni P, Chattopadhyay TK. The role of dual-phase helical CTin assessing resectability of carcinoma of the gallbladder. Eur Radiol. 2002;12(8):1993-1999.
65. Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg. 2007;11(5):671-681.
66. Corvera CU, Blumgart LH, Akhurst T, DeMatteo RP, D'Angelica M, Fong Y, Jarnagin WR. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg. 2008;206(1):57-65.
67. Pilgrim CHC, Usatoff V, Evans P. Consideration of anatomical structures relevant to the surgical strategy for managing gallbladder carcinoma. Eur J Surg Oncol. 2009;35(11):1131-1136.
68. Pilgrim C, Usatoff V, Evans PM. A review of the surgical strategies for the management of gallbladder carcinoma based on T stage and growth type of the tumour. Eur J Surg Oncol. 2009;35(9):903-907.
69. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273-1281.
70. Hyder O, Dodson RM, Sachs T, Weiss M, Mayo SC, Choti MA, et al. Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: A propensity score-matched Surveillance, Epidemiology, and End Results analysis. Surgery. 2013. pili: S0039-6060(13)00288-2.
71. Aaronson S. Growth Factors and Cancer. Science. 1991;254(5035):1146-1153.
72. Pignochino Y, Sarotto I, Peraldo-Neia C, Penachioni JY, Cavolloni G, Migliardi G, et al. Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliarytract and gallbladder carcinomas. BMC Cancer. 2010;10:631.
73. Ito H, Ito K, D'Angelica M, et al. Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg. 2011;254(2):320-325.
74. Pawlik TM, Gleisner AL, Vigano L, et al. Incidence of Finding Residual Disease for Incidental Gallbladder Carcinoma: Implications for Re-resection. J Gastrointest Surg. 2007;11(11):1478-86; discussion 1486-7.